Xilio Therapeutics Inc Sustainability Reports

Xilio Therapeutics Inc. is a biotechnology company focused on developing tumor-selective immuno-oncology therapies to enhance the treatment of cancer.

Sector: Health Care

Country: United States

Exchange: Nasdaq Stock Market

ISIN: US98422T1007

3 reports from 2022 to 2024

Company Profile

Xilio Therapeutics Inc

Xilio Therapeutics Inc. is a biotechnology company focused on developing tumor-selective immuno-oncology therapies to enhance the treatment of cancer.

MIC

 

Ticker

 

ISIN

 

Website

www.xiliotx.com

Country

United States

Exchange

Nasdaq Stock Market

Sector

Health Care

Industry

Pharmaceuticals, Biotechnology & Life Sciences

Reports

Available reports